Recurrent C. diff infection is when you contract a C. diff infection 2 to 8 weeks after completing treatment for a previous one. C. diff relapse is a recurrence of the same strain, while reinfection ...

About 10% of patients admitted to a hospital carried Clostridioides difficile, even though they had no active symptoms of the infection, researchers found. Moreover, almost 40% of these carriers ...

Clostridiumdifficile infection (also known as C. diff or CDI) is one of the most common hospital-acquired infections and is a frequent cause of death among hospitalized older adults. Keystone ...

Patients with Clostridioides difficile infection had different bacterial and fungal composition in their stool compared with that of uninfected patients, researchers found. Distinct species of fungus ...

Outcomes were worse for patients hospitalized once for Clostridioides difficile infection compared with alternative reasons for hospitalization, but the risk of adverse outcomes did not seem to ...

Clostridium difficile bacteria, computer illustration. C. difficile is a normal inhabitant of the human intestine, but it can become a pathogen when antibiotics disrupt the normal intestinal flora and ...

C. diff, which is short for Clostridioides difficile, is a type of bacteria that may cause serious problems in the digestive system. It is one of the most common causes of diarrhea linked to ...

Eat foods with probiotics like yogurt and kefir to help replenish good bacteria in your gut. A C. diff diet should include ...

New research assesses the efficacy of hospital disinfectants in killing off the superbug Clostridioides difficile. Share on Pinterest A new study shows that disinfectants do not completely eradicate C ...

Rachel works as a CRNA where she provides anesthesia care across the lifespan, including pediatric anesthesia, with a primary focus on orthopedic anesthesia. She is also an Assistant Professor at the ...

Data from the phase 3 study confirmed the lot consistency, immunogenicity, safety, and tolerability of a toxoid-based Clostridioides difficile vaccine. Neutralizing antibody responses 1 month after ...